Navigation Links
Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations
Date:3/19/2008

LONDON, March 19 /PRNewswire/ -- Solcara, the market-leading provider of software for the control, management and searching of digital information, has been helping AstraZeneca manage its interactions with the media through the use of Solcara Communications Centre.

AstraZeneca, one of the world's leading pharmaceutical companies, is a truly international company, and is active in over 100 countries, with its corporate office in London and major Research & Development (R&D) sites in Sweden, the UK and US. AstraZeneca's media relations team wanted a system that would create an accessible international benchmark for consistent media relations across all continents.

Solcara Communications Centre is a 'live' application which means the information stored within it can be accessed anywhere, anytime. AstraZeneca's key international media contacts have access to a user-friendly interface and information management system that enables key spokespeople to provide consistent information to the media "around the clock," regardless of their location.

The media relations department at AstraZeneca uses Solcara Communications Centre to manage journalist contact details, track enquiries from the media and log numerous interview requests. The software provides a simple and effective means of monitoring all press office activity, enabling the team to report on progress and productivity quickly and easily.

Rob Martin, Managing Director at Solcara said, "With hugely successful worldwide businesses such as AstraZeneca, protecting a reputation and communicating a coherent, consistent message on a global scale is becoming more and more important. AstraZeneca's strategic approach to communications is being adopted by a rapidly increasing number of major organisations who understand the importance of reputation. Like AstraZeneca, they are choosing Solcara Communications Centre because it supports global communications and removes barriers of time and locati
'/>"/>

SOURCE Solcara
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
2. Direct Anesthetic Infusion Helps Colorectal Cancer Patients
3. Radiation and drug combo helps boost efficacy of lung cancer treatment
4. Childs Flu Shot Helps Whole Family
5. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
6. Generic prostate drug helps find high-risk cancers early
7. Tamoxifen Helps Treat Bipolar Disorder
8. Imaging Software Helps Track, Treat Injured Brains
9. GPS-like technology helps pinpoint best methods for moving injured players
10. New Website Helps Women Be Fit, Sexy and in Control!
11. Brain Defect Helps Drive Fragile X Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...rasylol have a higher death risk, data review find...-- A new study casts more doubt on the safety of t...ng in patients undergoing surgery. , Trasylol i... States, where it was removed from the market in 2...n researchers reviewed findings from 49 randomized...
(Date:12/2/2008)...Dec. 2 Seniors, disable...ompanies gathered today to,oppose efforts by Blue...tion,through the lame duck session of the Legisla...death for many of us in Michigan," said,RoAnne Ch...ility Rights,Coalition. "A vote for this bill is ...
(Date:12/2/2008)...o)Rare injuries accounted for 3.5 percent of high ...ding to the first study to examine rare injuries a...njuries include eye injuries, dental injuries, nec...llness, which may result in high morbidity, costly...ences. , Football was associated with the highes...
(Date:12/2/2008)... Today, advocates for t...ntry are coming together at Liz,Claiborne Inc. to...top Teen,Dating Abuse. Ann and Chris Burke, educa...dered by her abusive ex-boyfriend, are joining eff... on this national coalition that will,consist of ...
Breaking Medicine News(10 mins):Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3
...the National Institutes of Health, United States, ...t -of –interests. This involves going against the ...l advice and help to a private company. Sutherland...s accused of proving the giant drug company, Pfize...
...ugs and radiation. But recent studies reveal that ...e mortality of cancer victims by 50 to 60 percent....e benefits of exercise in the prevention of hear...ittle is known about the effects of exercise on ca...
...olesterol, blood pressure and cardio-vascular prob...-based laboratory//. Pharmacists at Dr Reddy’s ha...olesterol-lowering statin, two blood-pressure medi...e world’s first ‘polypill’ is expected to control ...
... in Mars as believed earlier but ‘very liquid, ver...cient water on Mars," said Ken Edgett, a scientist...conference. "Today, we are talking about liquid wa...s right now.” The pictures taken by NASA's Mars G...
Other Medicine News:Health News:Poly-pill – A Single Drug For Multiple Complaint 2
(Date:12/1/2008)...e-USNewswire/ -- New research has found that the a...ography (CT) scanner in an emergency room can sign...o receive a potentially life-saving treatment. Res...l Center (NSMC)-Salem Hospital in Salem, Mass., wi... Radiological Society of North America (RSNA). , ...
(Date:12/1/2008)...ire/ -- TargeGen has announced that an oral,prese...r, US-based clinical,trial of TG101348 in myelopr...,the 2008 American Society of Hematology (ASH) Me...as follows:, Title: A Phase I S... JAK2-Selective Inhibitor, in Patie...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008).... 1 Genaera Corporation...subjects has begun in study MSI-1436C-102 (Study 1... trodusquemine (MSI-1436) in overweight and obese ...for the treatment of type 2 diabetes and obesity w...insulin and leptin pathways through the highly sel...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 1Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 2Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 4Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 5A reputation for innovation 4796 1A reputation for innovation 4796 2Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 1Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 1Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 3Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 4
...22, 2007 /PRNewswire/ -- Principal,investigators f...roliferative for Restenosis) trial, the pivotal st...luting coronary stent,presented today the clinica...investigators confirmed that the study failed to m...ed this conclusion in a,press release on Monday, M...
... FDA Approval of SEROQUEL XR--, WILMINGTON, Del., ... today announced that two analyses from a large-sc...EL XR(TM) (quetiapine,fumarate) Extended-Release T... schizophrenia in adult patients, were presented t...tric Association,(APA). These analyses from the cl...
Other Medicine Technology:Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 2Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
Wipe + Wick
Ophthalmic Ring
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2".
PremierEdge™ Slit Knives.
Medicine Products: